We are live on ! Find out more
CC

Cannell & Co Portfolio holdings

AUM $3.15B
1-Year Est. Return 30.62%
This Fund
S&P 500
This Quarter Est. Return
+11.95%
1 Year Est. Return
+30.62%
3 Year Est. Return
+51.59%
5 Year Est. Return
+187.25%
10 Year Est. Return
+311.58%
AUM
$3.15B
AUM Growth
+$229M
Cap. Flow
-$67.4M
Cap. Flow %
-2.14%
Top 10 Hldgs %
30.6%
Holding
280
New
21
Increased
58
Reduced
115
Closed
11

Top Buys

Rank Stock Value
1
CRH icon
CRH
CRH
+$43.1M
2
LH icon
Labcorp
LH
+$27.4M
3
PINS icon
Pinterest
PINS
+$23.5M
4
GE icon
GE Aerospace
GE
+$18.2M
5
CSX icon
CSX Corp
CSX
+$13.3M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$48.3M
2
VRT icon
Vertiv
VRT
+$31.6M
3
GPRE icon
Green Plains
GPRE
+$21.1M
4
KVUE icon
Kenvue
KVUE
+$19M
5
NTR icon
Nutrien
NTR
+$14.4M

Sector Composition

Rank Sector Weight
1 Technology 20.59%
2 Financials 15.93%
3 Industrials 13.18%
4 Healthcare 12.02%
5 Consumer Discretionary 10.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GE icon
51
GE Aerospace
GE
$346B
$20M 0.63%
+196,082
New +$18.2M
MDLZ icon
52
Mondelez International
MDLZ
$78.4B
$19.4M 0.62%
268,258
+2,208
+0.8% +$151K
GOOGL icon
53
Alphabet (Google) Class A
GOOGL
$4.19T
$19.3M 0.61%
137,824
-230
-0.2% -$30.9K
CMCSA icon
54
Comcast
CMCSA
$94.6B
$18.9M 0.6%
431,712
-6,535
-1% -$280K
HON icon
55
Honeywell
HON
$65.8B
$18.6M 0.59%
94,146
+8,752
+10% +$1.58M
ADBE icon
56
Adobe
ADBE
$114B
$18M 0.57%
30,239
-1,116
-4% -$644K
CCK icon
57
Crown Holdings
CCK
$12.6B
$18M 0.57%
195,127
+60,510
+45% +$5.13M
INTC icon
58
Intel
INTC
$485B
$17.6M 0.56%
349,686
-8,675
-2% -$352K
APD icon
59
Air Products & Chemicals
APD
$67.7B
$17.2M 0.54%
62,668
+4,801
+8% +$1.32M
KO icon
60
Coca-Cola
KO
$382B
$17.1M 0.54%
290,389
-4,090
-1% -$232K
XOM icon
61
ExxonMobil
XOM
$667B
$16.5M 0.52%
165,228
+544
+0.3% +$57.2K
CSX icon
62
CSX Corp
CSX
$90.8B
$16.5M 0.52%
475,970
+417,495
+714% +$13.3M
SYY icon
63
Sysco
SYY
$38.8B
$15.1M 0.48%
206,834
+35,089
+20% +$2.42M
BAX icon
64
Baxter International
BAX
$13.2B
$14.4M 0.46%
371,873
-21,420
-5% -$758K
JPM icon
65
JPMorgan Chase
JPM
$962B
$14.3M 0.45%
83,796
+1,563
+2% +$237K
BMY icon
66
Bristol-Myers Squibb
BMY
$139B
$14.1M 0.45%
274,317
-25,073
-8% -$1.32M
FNF icon
67
Fidelity National Financial
FNF
$12.7B
$13.8M 0.44%
270,340
-1,169
-0.4% -$50.9K
HCA icon
68
HCA Healthcare
HCA
$88.6B
$13.7M 0.44%
50,687
-2,393
-5% -$591K
QDEL icon
69
QuidelOrtho
QDEL
$955M
$13.5M 0.43%
183,174
-33,355
-15% -$2.26M
FNV icon
70
Franco-Nevada
FNV
$52.1B
$12.1M 0.39%
109,482
-72,763
-40% -$8.85M
UNP icon
71
Union Pacific
UNP
$172B
$11.8M 0.38%
48,175
+928
+2% +$204K
RTX icon
72
RTX Corp
RTX
$272B
$10.9M 0.35%
129,457
+1,346
+1% +$107K
FCNCA icon
73
First Citizens BancShares
FCNCA
$24.9B
$10.8M 0.34%
7,617
-135
-2% -$190K
AFL icon
74
Aflac
AFL
$59.3B
$10.2M 0.32%
123,751
-9,447
-7% -$761K
PAR icon
75
PAR Technology
PAR
$782M
$10M 0.32%
230,573
-57,838
-20% -$2.17M

Similar funds

Cannell & Co's Q4 2023 Portfolio in Review

As of Q4 2023, Cannell & Co held 280 positions worth $3.15B, up 7.8% from $2.92B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Cannell & Co's Q4 2023 filing shows 21 new, 58 increased, 115 reduced and 11 closed positions. Its largest new stake was CRH: 714,012 shares worth $49.4M. The largest sale was Humana, an estimated $48.3M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.

  • Cannell & Co's largest Q4 2023 buy was CRH: 714,012 shares worth $49.4M.
  • Cannell & Co added most to Labcorp in Q4 2023, an estimated $27.4M increase.
  • Cannell & Co's biggest Q4 2023 reduction was Humana, cutting an estimated $48.3M.
  • Cannell & Co fully exited Nutrien in Q4 2023, selling an estimated $14.4M.
  • Cannell & Co's ten largest holdings make up 31% of its $3.15B portfolio in Q4 2023.
  • Cannell & Co opened 21 new positions and closed 11 in Q4 2023.
  • Cannell & Co's portfolio value rose 7.8% quarter-over-quarter to $3.15B.

Based on Cannell & Co's 13F filing for Q4 2023, filed 5 Feb 2024.